When to stop Mounjaro before surgery: what UK guidance says

Why gastric emptying is the central concern

The starting point here is physiology, not pharmacology paperwork. GLP-1 and GIP receptor agonists like tirzepatide work, in part, by slowing the rate at which the stomach empties its contents into the small intestine. That mechanism is useful for appetite and blood-sugar control day to day. Before surgery, it creates a genuine clinical problem.

General anaesthesia suppresses protective airway reflexes. If solid or liquid stomach contents are still present (even after the standard fasting window) there is a risk of pulmonary aspiration: stomach material entering the lungs. The consequences can be serious. NHS England's guidance on weight-management injections explicitly advises patients to tell their healthcare team and anaesthetist that they are taking a GLP-1 medicine before any surgical procedure, precisely because standard pre-operative fasting rules were developed before this drug class existed. NHS England's wraparound care guidance covers this directly.

The Royal College of Anaesthetists and several NHS trusts have issued their own local advisories in line with this concern. The consensus position is that delayed gastric emptying on GLP-1 medicines means the standard fasting period may not be sufficient to guarantee an empty stomach.

How long before surgery to stop Mounjaro, UK guidance in practice

For most people taking once-weekly Mounjaro, UK anaesthetic teams currently advise stopping at least one full week before a planned general anaesthetic. That means skipping your scheduled injection the week before your operation date. Some teams extend this to two weeks for higher doses or longer-duration procedures; a small number of surgical units are now asking for a full four-week pause for elective cases. If you are weighing up the timing, our dedicated page on whether you need to stop Mounjaro before surgery walks through how the decision is reached for different patient situations.

The detail on stopping Mounjaro before surgery matters here: a week's pause does not mean a week of missed benefit, tirzepatide has a half-life of roughly five days, so its effects on gastric motility do begin to wane, but individual variation is real. Your prescriber can advise on the timing that makes clinical sense for your situation.

One practical note: if your Mounjaro pen is kept in the fridge door, the usual weekly routine makes it straightforward to identify exactly which injection to skip. Knowing the date of your procedure well in advance gives both you and your surgical team time to plan without a last-minute scramble.

What is still uncertain, and what that means for you

Honest answer: the evidence base here is still developing. There are no large randomised trials specifically measuring aspiration rates in GLP-1 users versus non-users during surgery. The guidance that exists is largely expert consensus and case-series data, extrapolated from what is known about the medicine's pharmacodynamics. The clinical picture around tirzepatide and surgery is evolving, and individual NHS trusts are not yet fully standardised on the exact cessation window.

What that uncertainty does not mean is that the risk is theoretical. Aspiration during anaesthesia is a serious event, and even a small increase in probability matters. It also does not mean you should make the call yourself. Understanding why you cannot take Mounjaro before surgery goes beyond a simple rule, rooted instead in how the medicine changes the physiology that anaesthetists depend on managing safely. The NHS patient guide to tirzepatide is clear that you should inform every healthcare professional involved in your care that you are taking it.

There is also the question of restarting. Many patients ask whether they can go straight back to their usual dose after the operation. The safe answer is: not necessarily, and not without checking. Nausea and reduced appetite are common in the post-operative recovery period, and reintroducing a GLP-1 medicine too soon can compound those effects. Your prescriber will want to know that you are eating and drinking normally again before advising a restart. If you have questions about your specific plan, the aftercare team at nume is available seven days a week.

How to act on this before your operation

The steps are straightforward, even if the clinical picture has nuance. First, tell your surgical team and anaesthetist you are on Mounjaro as early as possible, ideally at your initial consultation or pre-operative assessment, not the day before. Second, contact your prescriber (at nume, that is a GPhC-registered Independent Prescriber, not an automated system) and let them know the operation date and procedure type. They can document the pause, advise on timing, and confirm a plan for restarting. Third, follow the fasting instructions your anaesthetist gives you exactly, GLP-1 users may be given extended fasting requirements beyond the usual nil-by-mouth window.

For emergency surgery, there is no time to pause the medicine. In that scenario, the anaesthetic team must simply be told you have been taking it and when your last dose was, which is another reason to keep that information easy to communicate. Carrying a brief written note of your medication and dose in your phone or wallet is a habit worth forming. You can read more about Mounjaro and surgery generally, including what the research says about scheduled versus emergency procedures.

If you are considering starting Mounjaro or reviewing your treatment plan ahead of a procedure, the right first step is a clinical conversation. Check your eligibility with our prescribers and raise your surgical timeline at that stage.